Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1-Reference-Cited by-同舟云学术

Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1

Published:2017-04-13 Issue:5 Volume:27 Page:527-538
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Plano Daniel¹²,Alcolea Verónica¹²,Sanmartín Carmen¹²,Sharma Arun K.³

Affiliation:

1. University of Navarra, Faculty of Pharmacy and Nutrition, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, Pamplona, Spain

2. IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain

3. Department of Pharmacology, Penn State Cancer Institute, Hershey, PA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1315103

Reference54 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

2. Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis

3. Biomarkers for Predicting the Efficacy of Anti-Epidermal Growth Factor Receptor Antibody in the Treatment of Colorectal Cancer

4. FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors;BMC Cancer;2020-02-17

2. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs;Cancer Control;2019-01-01

3. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data;World Journal of Gastrointestinal Oncology;2018-07-15